Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Lonza Acquires Synaffix
Thursday, June 01, 2023Lonza announced that it has acquired Synaffix for the development of AntibodyDrug Conjugates ADCs
Bayer Announces Exclusive Licence Agreement with Cedilla Therapeutics
Thursday, June 01, 2023Bayer and Cedilla Therapeutics have recently entered into an exclusive licence agreement to collaborate on the development and commercialisation of Cedilla Therapeutics CyclinECDK complex inhibitors
SGS receives WHO-PQT approval for its Navi Mumbai laboratory, bolstering support to the global pharma industry
Wednesday, May 31, 2023Wednesday May Mumbai SGS is proud to announce that our Health Science laboratory based in Navi Mumbai has received the approval of the World Health Organization Geneva Prequalification Unit PQT for testing analytical services and stability studies
RP-A501 Gene Therapy Granted Priority Medicines (PRIME) Designation by Rocket Pharmaceuticals
Wednesday, May 31, 2023Rocket Pharmaceuticals announced that the European Medicines Agency EMA has granted Priority Medicines PRIME designation to RPA the investigational adenoassociated virus AAVbased gene therapy
The University of Sydney Enters into Memorandum of Understanding (MoU) with Pharos Therapeutics
Tuesday, May 30, 2023The University of Sydney has signed a memorandum of understanding MoU with Pharos Therapeutics the Australian subsidiary of South Korean pharmaceutical company Pharos iBio
Sun Pharma and Philogen Enter into an Exclusive Distribution, Licence, and Supply Agreement for NIDLEGY™
Tuesday, May 30, 2023Sun Pharma and Philogen have recently entered into an exclusive distribution licence and supply agreement This strategic partnership aims to facilitate the commercialisation of the innovative speciality product NIDLEGY in the regions of Europe Austra...
Takeda and HUTCHMED Announce FDA New Drug Application (NDA) for Fruquintinib
Friday, May 26, 2023Takeda and HUTCHMED announced that the US Food and Drug Administration FDA has granted priority review of the New Drug Application NDA for fruquintinib a highly selective and potent inhibitor of vascular endothelial growth factor receptors VEGFR an...
Pfizer Announces FDA Approval of PAXLOVID™ for Adult Patients
Friday, May 26, 2023Pfizer announced that the US Food and Drug Administration FDA has approved PAXLOVID nirmatrelvir tablets and ritonavir tablets for the treatment of mildtomoderate COVID in adults who are at high risk for progression to severe COVID including hospital...
Bristol Myers Squibb and Janssen Pharmaceuticals Collaborate to Receive FDA Fast Track Designation for Milvexian
Thursday, May 25, 2023Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals announced that all three prospective indications for milvexian an investigational oral factor XIa FXIa inhibitor have now been granted Fast Track Designation by the US Food and Drug A...
Novo Nordisk Collaborates with Life Edit Therapeutics
Thursday, May 25, 2023Novo Nordisk and Life Edit Therapeutics announced a research and development collaboration to discover and develop gene editing therapies against a select set of therapeutic targets
